Nuclear receptor subfamily 5, group A, member 2 (NR5A2, BIF2, FTZ-F1beta) is a transcription factor involved in cholesterol transport, bile acid homeostasis and steroidogenesis. Also known as liver receptor homolog-1, LRH-1 is expressed primarily in liver, intestine, exocrine pancreas, ovary and embryonic stem cells (ESC). LRH-1 regulates the expression of the key bile acid biosynthetic enzyme cholesterol 7alpha hydroxylase (Cyp7A1).
Synonyms: Anti-B1F; Anti-B1F2; Anti-CPF; Anti-FTF; Anti-FTZ-F1; Anti-FTZ-F1beta; Anti-LRH-1; Anti-Nuclear receptor subfamily 5, group A, member 2
MDL Number: MFCD07370495
Storage: -20C
Application: Anti-NR5A2 polyclonal antibody is used to tag liver receptor homolog-1 protein for detection and quantitation by Western blotting and in plasma by immunohistochemical (IHC) techniques. It is used as a probe to determine the roles of liver receptor homolog-1 in the regulation of bile acid biosynthesis, cholesterol transport and steroidogenesis.
Biochem Physiol Actions: NR5A2 binds to the sequence element 5'-AACGACCGACCTTGAG-3' of the enhancer II of hepatitis B virus genes, a critical cis-element of their expression and regulation. It may be responsable for the liver-specific activity of enhancer II, probably in combination with other hepatocyte transcription factors. It is a key regulator of cholesterol 7-alpha-hydroxylase gene (CYP7A) expression in liver. It may also contribute to the regulation of pancreas-specific genes and play important roles in embryonic development.